Tsuji Takao, Kelly Neil J, Takahashi Saeko, Leme Adriana S, Houghton A McGarry, Shapiro Steven D
1 Department of Medicine, UPMC and University of Pittsburgh, Pittsburgh, Pennsylvania.
Am J Respir Cell Mol Biol. 2014 Dec;51(6):822-9. doi: 10.1165/rcmb.2014-0083OC.
Macrophage elastase (MMP12) is a key mediator of cigarette smoke (CS)-induced emphysema, yet its role in other smoking related pathologies remains unclear. The weight suppressing effects of smoking are a major hindrance to cessation efforts, and MMP12 is known to suppress the vascularization on which adipose tissue growth depends by catalyzing the formation of antiangiogenic peptides endostatin and angiostatin. The goal of this study was to determine the role of MMP12 in adipose tissue growth and smoking-related suppression of weight gain. Whole body weights and white adipose depots from wild-type and Mmp12-deficient mice were collected during early postnatal development and after chronic CS exposure. Adipose tissue specimens were analyzed for angiogenic and adipocytic markers and for content of the antiangiogenic peptides endostatin and angiostatin. Cultured 3T3-L1 adipocytes were treated with adipose tissue homogenate to examine its effects on vascular endothelial growth factor (VEGF) expression and secretion. MMP12 content and activity were increased in the adipose tissue of wild-type mice at 2 weeks of age, leading to elevated endostatin production, inhibition of VEGF secretion, and decreased adipose tissue vascularity. By 8 weeks of age, adipose MMP12 levels subsided, and the protein was no longer detectable. However, chronic CS exposure led to macrophage accumulation and restored adipose MMP12 activity, thereby suppressing adipose tissue mass and vascularity. Our results reveal a novel systemic role for MMP12 in postnatal adipose tissue expansion and smoking-associated weight loss by suppressing vascularity within the white adipose tissue depots.
巨噬细胞弹性蛋白酶(基质金属蛋白酶12,MMP12)是香烟烟雾(CS)诱导的肺气肿的关键介质,但其在其他吸烟相关病理中的作用仍不清楚。吸烟的体重抑制作用是戒烟努力的主要障碍,已知MMP12通过催化抗血管生成肽内皮抑素和血管抑素的形成来抑制脂肪组织生长所依赖的血管生成。本研究的目的是确定MMP12在脂肪组织生长和吸烟相关的体重增加抑制中的作用。在出生后早期发育期间以及慢性CS暴露后,收集野生型和Mmp12基因缺陷小鼠的全身重量和白色脂肪库。分析脂肪组织标本中的血管生成和脂肪细胞标记物以及抗血管生成肽内皮抑素和血管抑素的含量。用脂肪组织匀浆处理培养的3T3-L1脂肪细胞,以检查其对血管内皮生长因子(VEGF)表达和分泌的影响。野生型小鼠在2周龄时脂肪组织中的MMP12含量和活性增加,导致内皮抑素产生增加、VEGF分泌受到抑制以及脂肪组织血管生成减少。到8周龄时,脂肪组织中的MMP12水平下降,该蛋白不再可检测到。然而,慢性CS暴露导致巨噬细胞积聚并恢复了脂肪组织中的MMP12活性,从而抑制了脂肪组织质量和血管生成。我们的结果揭示了MMP12在出生后白色脂肪组织库内通过抑制血管生成在脂肪组织扩张和吸烟相关体重减轻中的一种新的全身作用。